• 8904 Citations

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

I am interested in building relationships with companies and other institutions who provide novel treatments for sarcoma patients at the Siteman Cancer Center

Fingerprint Dive into the research topics where Brian Van Tine is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft-tissue sarcomas who are not candidates for chemotherapy

Hirbe, A. C., Eulo, V., Moon, C. I., Luo, J., Myles, S., Seetharam, M., Toeniskoetter, J., Kershner, T., Haarberg, S., Agulnik, M., Monga, V., Milhem, M., Parkes, A., Robinson, S., Okuno, S., Attia, S. & Van Tine, B., Sep 2020, In : European Journal of Cancer. 137, p. 1-9 9 p.

Research output: Contribution to journalArticle

Open Access
  • A retrospective analysis of the efficacy of immunotherapy in metastatic soft-tissue sarcomas

    Monga, V., Skubitz, K. M., Maliske, S., Mott, S. L., Dietz, H., Hirbe, A. C., Van Tine, B. A., Oppelt, P., Okuno, S., Robinson, S., O’connor, M., Seetharam, M., Attia, S., Charlson, J., Agulnik, M. & Milhem, M., Jul 2020, In : Cancers. 12, 7, p. 1-10 10 p., 1873.

    Research output: Contribution to journalArticle

    Open Access
  • Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States

    Pollack, S. M., Somaiah, N., Araujo, D. M., Druta, M., Van Tine, B. A., Burgess, M. A., Chawla, S. P., Seetharam, M., Okuno, S. H., Bohac, C., Chen, M., Yurasov, S. & Attia, S., Jul 1 2020, In : Cancer medicine. 9, 13, p. 4593-4602 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • Correlative analyses of the SARC028 trial reveal an association between sarcoma-associated immune infiltrate and response to pembrolizumab

    Keung, E. Z., Burgess, M., Salazar, R., Parra, E. R., Rodrigues-Canales, J., Bolejack, V., Van Tine, B. A., Schuetze, S. M., Attia, S., Riedel, R. F., Hu, J., Okuno, S. H., Priebat, D. A., Movva, S., Davis, L. E., Reed, D. R., Reuben, A., Roland, C. L., Reinke, D., Lazar, A. J. & 3 others, Wang, W. L., Wargo, J. A. & Tawbi, H. A., Mar 15 2020, In : Clinical Cancer Research. 26, 6, p. 1258-1266 9 p.

    Research output: Contribution to journalArticle

  • 6 Scopus citations

    Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients with Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial

    Tap, W. D., Wagner, A. J., Schöffski, P., Martin-Broto, J., Krarup-Hansen, A., Ganjoo, K. N., Yen, C. C., Abdul Razak, A. R., Spira, A., Kawai, A., Le Cesne, A., Van Tine, B. A., Naito, Y., Park, S. H., Fedenko, A., Pápai, Z., Soldatenkova, V., Shahir, A., Mo, G., Wright, J. & 1 others, Jones, R. L., Apr 7 2020, In : JAMA - Journal of the American Medical Association. 323, 13, p. 1266-1276 11 p.

    Research output: Contribution to journalArticle

  • 8 Scopus citations